370 related articles for article (PubMed ID: 28583397)
21. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
[TBL] [Abstract][Full Text] [Related]
22. Cardiotoxicity: anthracyclines and long term cancer survivors.
Patanè S
Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
[No Abstract] [Full Text] [Related]
23. Improving paediatric cardiologists' awareness about the needs of childhood cancer survivors: results of a single-centre directed educational initiative.
Rose-Felker K; Effinger K; Kelleman MS; Sachdeva R; Meacham LR; Border WL
Cardiol Young; 2019 Jun; 29(6):808-812. PubMed ID: 31280730
[TBL] [Abstract][Full Text] [Related]
24. Cardiotoxicity: cisplatin and long-term cancer survivors.
Patanè S
Int J Cardiol; 2014 Jul; 175(1):201-2. PubMed ID: 24820740
[No Abstract] [Full Text] [Related]
25. Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment.
Oikonomou E; Anastasiou Μ; Siasos G; Androulakis E; Psyrri A; Toutouzas K; Tousoulis D
Curr Pharm Des; 2018; 24(37):4424-4435. PubMed ID: 30636595
[TBL] [Abstract][Full Text] [Related]
26. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer.
Tukenova M; Guibout C; Oberlin O; Doyon F; Mousannif A; Haddy N; Guérin S; Pacquement H; Aouba A; Hawkins M; Winter D; Bourhis J; Lefkopoulos D; Diallo I; de Vathaire F
J Clin Oncol; 2010 Mar; 28(8):1308-15. PubMed ID: 20142603
[TBL] [Abstract][Full Text] [Related]
27. Hypertension in Cancer Survivors: A Review of the Literature and Suggested Approach to Diagnosis and Treatment.
Chuquin D; Abbate A; Bottinor W
J Cardiovasc Pharmacol; 2022 Oct; 80(4):522-530. PubMed ID: 36027586
[TBL] [Abstract][Full Text] [Related]
28. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular and Pulmonary Challenges After Treatment of Childhood Cancer.
Visscher H; Otth M; Feijen EAML; Nathan PC; Kuehni CE
Pediatr Clin North Am; 2020 Dec; 67(6):1155-1170. PubMed ID: 33131539
[TBL] [Abstract][Full Text] [Related]
30. Chronic cardiovascular toxicity in the older oncology patient population.
Findlay SG; Gill JH; Plummer R; DeSantis C; Plummer C
J Geriatr Oncol; 2019 Sep; 10(5):685-689. PubMed ID: 30733001
[TBL] [Abstract][Full Text] [Related]
31. Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.
Shelburne N; Simonds NI; Adhikari B; Alley M; Desvigne-Nickens P; Dimond E; Filipski K; Gallicchio L; Minasian L
Curr Oncol Rep; 2019 Jan; 21(1):9. PubMed ID: 30701318
[TBL] [Abstract][Full Text] [Related]
32. The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.
Pituskin E; Paterson I; Cox-Kennett N; Rothe D; Perri M; Becher H
Semin Oncol Nurs; 2017 Nov; 33(4):384-392. PubMed ID: 28941563
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors.
Haugnes HS; Oldenburg J; Bremnes RM
Urol Oncol; 2015 Sep; 33(9):399-406. PubMed ID: 25554583
[TBL] [Abstract][Full Text] [Related]
34. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
35. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
Boekel NB; Schaapveld M; Gietema JA; Russell NS; Poortmans P; Theuws JC; Schinagl DA; Rietveld DH; Versteegh MI; Visser O; Rutgers EJ; Aleman BM; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1061-72. PubMed ID: 27026313
[TBL] [Abstract][Full Text] [Related]
37. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
[TBL] [Abstract][Full Text] [Related]
38. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
39. Echocardiography and Cardio-Oncology.
Negishi T; Miyazaki S; Negishi K
Heart Lung Circ; 2019 Sep; 28(9):1331-1338. PubMed ID: 31230869
[TBL] [Abstract][Full Text] [Related]
40. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
